News
1h
Zacks Investment Research on MSNBAX Stock May Rise Following the Launch of FDA-Approved Hemopatch PadBaxter International BAX announced the launch of Hemopatch Sealing Hemostat in the United States. This innovative, ...
Mirae Asset Global ETFs Holdings Ltd. boosted its CVS Health holdings by a hearty 34.2%, buying an extra 86,715 shares during ...
This was the stock's fourth consecutive day of gains.
On May 19, Guy P Sansone, Board Member at CVS Health CVS +0.19% Get Free Report executed a significant insider buy, as disclosed in the latest SEC filing.
What Happened: Kirby made a significant move by purchasing 2,769 shares of CVS Health as reported in a Form 4 filing with the U.S. Securities and Exchange Commission. The transaction's total worth ...
Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain with precision and safety.
Nan Shan Life Insurance trimmed its CVS Health stake by 4.7%, reducing its holdings by 21,740 shares in Q4. CVS Health shares ...
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” first quarter 2025 ...
BDX unveils the BD FACSDiscover A8, a next-gen cell analyzer with spectral flow cytometry and real-time imaging, enabling deeper insights into cell function and biology.
Perhaps it’s not all too surprising to witness the S&P 500 run into turbulence after two of the best years for stock gains in ...
UnitedHealth Group faces real PBM reform risks, but legal paths, financials, and market pricing suggest opportunity in ...
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results